//New Scientist article sheds light on role of porphyromonas gingivalis in Alzheimer’s

New Scientist article sheds light on role of porphyromonas gingivalis in Alzheimer’s

The recent online article in New Scientist, “We may finally know what causes Alzheimer’s – and how to stop it,” by Debora MacKenzie is fueling many discussions around the internet and within the infectious disease research industry. These conversations discuss the results of research by Cortexyme that a new drug to block porphyromonas gingivalis (P. gingivalis) might also stop and reverse Alzheimer’s disease. While the theory and research is not proven yet, it is fueling fires that germ research is an area within Alzheimer’s that must command more attention and funding.

Most promising is that the researchers at Cortexyme determined “…the toxic enzymes – called gingipains – that P. gingivalis uses to feed on human tissue in 96 per cent of the 54 Alzheimer’s brain samples they looked at, and found the bacteria themselves in all three Alzheimer’s brains whose DNA they examined.”

2019-01-25T11:22:32+00:00 January 25, 2019|News|